BlackRock Inc. - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 115 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,479,790
-21.6%
2,473,356
-2.3%
0.00%
Q2 2023$17,190,780
+45.3%
2,531,779
+7.2%
0.00%
Q1 2023$11,829,077
-6.0%
2,361,093
-8.4%
0.00%
Q4 2022$12,584,427
-69.9%
2,578,776
-11.0%
0.00%
-100.0%
Q3 2022$41,780,000
-7.2%
2,897,394
-2.6%
0.00%0.0%
Q2 2022$45,031,000
+28.7%
2,976,221
+1.1%
0.00%0.0%
Q1 2022$34,986,000
-22.0%
2,945,094
+6.4%
0.00%0.0%
Q4 2021$44,859,000
-42.6%
2,767,360
+1.1%
0.00%
-50.0%
Q3 2021$78,110,000
-14.5%
2,736,860
+1.2%
0.00%
-33.3%
Q2 2021$91,385,000
+19.7%
2,703,691
+7.1%
0.00%
+50.0%
Q1 2021$76,350,000
-36.2%
2,524,776
+4.4%
0.00%
-50.0%
Q4 2020$119,744,000
+33.0%
2,418,580
+3.1%
0.00%
+33.3%
Q3 2020$90,053,000
-9.8%
2,345,757
+1.5%
0.00%
-25.0%
Q2 2020$99,869,000
+93.2%
2,311,792
+16.8%
0.00%
+33.3%
Q1 2020$51,680,000
-17.9%
1,980,069
-1.6%
0.00%
+50.0%
Q4 2019$62,910,000
+82.3%
2,013,091
+52.0%
0.00%
+100.0%
Q3 2019$34,518,000
+30.8%
1,324,567
+14.8%
0.00%0.0%
Q2 2019$26,387,000
+172.7%
1,153,831
+212.6%
0.00%
Q1 2019$9,676,000
+39.2%
369,159
+8.0%
0.00%
Q4 2018$6,952,000
+1646.7%
341,831
+2178.9%
0.00%
Q3 2018$398,00015,0000.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$1,041,9094.24%
Sofinnova Investments, Inc. 2,194,278$11,958,8150.75%
DENALI ADVISORS LLC 85,900$468,1550.16%
Polar Capital Holdings Plc 2,103,298$11,462,9740.08%
Soleus Capital Management, L.P. 157,182$856,6420.08%
GSA CAPITAL PARTNERS LLP 137,299$7480.06%
Caligan Partners LP 23,321$127,0990.06%
Corton Capital Inc. 12,244$66,7300.03%
RICE HALL JAMES & ASSOCIATES, LLC 91,249$497,3070.03%
CIM INVESTMENT MANAGEMENT INC 15,313$83,4560.03%
View complete list of Y-MABS THERAPEUTICS INC shareholders